Zacks Investment Research
14 Sept 2026, 10:31 UTC · 2h ago
Verdict
Source says Buy. We score TX +0.90 across three claims.
Score confirms the headline.
Buy
Rating stated in the headline
+0.90strongly bullish
What the story claims
3 claims · scored −1 bearish … +1 bullish
The Zacks Consensus Estimate for Ternium S.A.'s current year earnings has increased 26.7% over the last 60 days.
More positive than 77% of claims this week
Takeda Pharmaceutical Company Limited's current year earnings estimates have increased 10.7% over the last 60 days.
Continue reading
5 related stories
More positive than 96% of ticker scores this week
Scored by the NIS engine · methodology.
More positive than 55% of claims this week
HP Inc.'s current year earnings estimates have increased 8.4% over the last 60 days.
More positive than 55% of claims this week
Which stocks this story touches
More positive than 96% of ticker scores this week
Assigned a Zacks Rank #1 (Strong Buy) with increasing earnings estimates and a high dividend yield.
More positive than 96% of ticker scores this week
Assigned a Zacks Rank #1 (Strong Buy) with increasing earnings estimates and a high dividend yield.
More positive than 96% of ticker scores this week
Assigned a Zacks Rank #1 (Strong Buy) with increasing earnings estimates and a high dividend yield.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
1h ago
—
TX hasn't traded since this ran. Last close $57.90 (Sep 11); the reaction starts at the next open.
TX chart →
